Genelux GNLX
NASDAQ GNLX
$2.72 -0.02 (-0.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Shares Outstanding (Entity) (2022 - 2026)

Genelux (GNLX) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Genelux 119.87 Mn 119.87 Mn - 44.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.84 Mn
Dec 31, 2025 38.14 Mn
Sep 30, 2025 38.05 Mn
Jun 30, 2025 37.76 Mn
Mar 31, 2025 37.73 Mn
Dec 31, 2024 34.73 Mn
Sep 30, 2024 34.54 Mn
Jun 30, 2024 34.51 Mn
Mar 31, 2024 27.00 Mn
Dec 31, 2023 26.79 Mn
Sep 30, 2023 26.66 Mn
Jun 30, 2023 25.86 Mn
Mar 31, 2023 19.58 Mn
Dec 31, 2022 9.12 Mn
Sep 30, 2022 9.12 Mn
Mar 31, 2022 9.11 Mn